Distinct Spatio-Temporal Dynamics of Tumor-Associated Neutrophils in Small Tumor Lesions

Front Immunol. 2019 Jun 25:10:1419. doi: 10.3389/fimmu.2019.01419. eCollection 2019.

Abstract

Across a majority of cancer types tumor-associated neutrophils (TAN) are linked with poor prognosis. However, the underlying mechanisms, especially the intratumoral behavior of TAN, are largely unknown. Using intravital multiphoton imaging on a mouse model with neutrophil-specific fluorescence, we measured the migration of TAN in distinct compartments of solid tumor cell lesions in vivo. By longitudinally quantifying the infiltration and persistence of TAN into growing tumors in the same animals, we observed cells that either populated the peripheral stromal zone of the tumor (peritumoral TAN) or infiltrated into the tumor core (intratumoral TAN). Intratumoral TAN showed prolonged tumor-associated persistence and reduced motility compared to peritumoral TAN, whose velocity increased with tumor progression. Selective pharmacological blockade of CXCR2 receptors using AZD5069 profoundly inhibited recruitment of TAN into peritumoral regions, while intratumoral infiltration was only transiently attenuated and rebounded at later time points. Our findings unravel distinct spatial dynamics of TAN that are partially and differentially regulated via the CXCR2 signaling pathway.

Keywords: AZD5069; CXCR2; intravital imaging; multiphoton microscopy; neutrophil granulocytes; tumor immunology; tumor microenvironment; tumor-associated neutrophils.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Mice
  • Neoplasms, Experimental / drug therapy
  • Neoplasms, Experimental / immunology*
  • Neoplasms, Experimental / pathology
  • Neutrophil Infiltration / drug effects
  • Neutrophil Infiltration / immunology*
  • Neutrophils / immunology*
  • Neutrophils / pathology
  • Pyrimidines / pharmacology
  • Receptors, Interleukin-8B / antagonists & inhibitors
  • Receptors, Interleukin-8B / immunology
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / immunology*
  • Skin Neoplasms / pathology
  • Sulfonamides / pharmacology

Substances

  • Cxcr2 protein, mouse
  • N-(2-(2,3-difluoro-6-benzylthio)-6-(3,4-dihydroxybutan-2-yloxy)pyrimidin-4-yl)azetidine-1-sulfonamide
  • Pyrimidines
  • Receptors, Interleukin-8B
  • Sulfonamides